PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Neurology Neuroimmunology & Neuroinflammation2 citationsOpen Access

TRUE-MOGAD Score

View Full Paper
AVAndreu VilasecaAFAngeliki FilippatouYSYana Said

Key Points

  • The aim is to create a scoring tool for interpreting MOG antibodies to reduce false positives in MOGAD cases.
  • Analysis of MOG antibody results
  • Development of a scoring system
  • Validation of the scoring tool against known cases
  • The scoring tool improves accuracy in interpreting MOG antibodies
  • Reduces false positive rates in MOGAD classification

Abstract

Myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-IgG) are a biomarker of MOG antibody-associated disease (MOGAD). However, false positives remain common. We aimed to develop a scoring tool to guide interpretation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Vilaseca et al. (2026) studied this question.

synapsesocial.com/papers/69cf5e2e5a333a821460c4d1https://doi.org/10.1212/nxi.0000000000200563
Ask AI
Helpful
Bookmark
Share
View Full Paper